Liposomal blood pool agents for nuclear medicine and magnetic resonance imaging

Journal of Liposome Research

Volumn 4, Issue 2, 1994, Pages 909-936

  Tilcock, Colin ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; GADOLINIUM PENTETATE; LIPOSOME; MANGANESE; RADIOISOTOPE;

ANIMAL EXPERIMENT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SYNTHESIS; ERYTHROCYTE STRUCTURE; IMAGE QUALITY; ISOTOPE LABELING; KIDNEY CLEARANCE; LIPID VESICLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; SCINTIANGIOGRAPHY;

EID: 0027968242     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109409018609     Document Type: Article

References (74)

1. Radionuclide assessment of cardiovascular performance
2. Gated equilibrium radionuclide angiography
3. Radionuclide cineangiography in acute myocardial infraction; role in prognostication
4. Use of radionuclide measurements of left ventricular function for prognosis in patients with coronary artery disease
5. Exercise radionuclide angiocardiography: Predicts cardiac death in patients with coronary heart disease
6. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: A comparison with clinical and catheterization variables
7. Magnetic Resonance Angiography
8. MR Angiography of peripheral, carotid and coronary arteries
9. Contrast enhancement of myocardium
10. Measurement of capIIIary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique
11. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia
12. The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on the salvage of ischemic myocardium in dogs
13. Salvage of myocardial function by coronary artery reperfusion 1,2, and 3 hours after occlusion in conscious dogs
14. Early detection of canine myocardial infarction by magnetic resonance imaging
15. Rapid Scan Techniques
16. First-pass cardiac perfusion: evaluation with ultrafast MR imaging
17. Fate and behavior of liposomes in vivo: a review of controlling factors
18. Effect of non-ionic surfactants on the stability of dispersions
19. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol
20. Some properties of polyethylene glycol: phenylalanine ammonia-lyase adducts
21. Liposomes for sustained drug release in vivo
22. Agents for inhibiting adsorption of proteins on the liposome surface
23. Amphipathic polyethylene glycols effectively prolong the circulation time of liposomes
24. Uptake of liposomes by cultured bone marrow macrophages:influence of liposome composition and size
25. Influence of surface hydrophilicity of liposomes on their interaction with plasma proteins and clearance from the circulation: studies with polyethylene glycol-coated vesicles
26. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target
27. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
28. Sterically stabilized liposomes: significant improvements in blood clearance, tissue deposition and therapeutic index of encapsulated drugs against implanted tumors
29. Amphipathic poly(ethylene glycol) 5000-stabilized dioleoylphosphatidylethanolamine liposomes accumulate in spleen, Biochim
30. Sterically stabilized liposomes
31. Polymer-derivatized technetium-99m-labeled liposomal blood pool agents for nuclear medicine applications
32. 67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents
33. Protein adsorption to and elution from polyether surfaces
34. Techniques to study the opsonic effect of serum on uptake of liposomes by phagocytic cells from various organs of the RES
35. Large unilamellar liposomes with low uptake into the reticuloendothelial system
36. Synthesis and characterization of poly(ethylene glycol) derivatives
37. The toxicology of high molecular weight polyethylene glycols; chronic oral and parental administration
38. Radiopharmaceuticals for cardiac imaging: myocardial infarction, perfusion, metabolism and ventricular function (blood pool)
39. Iatrogenic alterations in the biodistribution of radiotracers as a result of drug therapy: reported instances
40. The labeling of liposomal membranes with radioactive technetium
41. Technical and biological considerations on the use of radiolabeled liposomes for diagnostic imaging
42. Radiolabeled liposomes as metabolic and scanning tracers in mice II. In-III oxime compared to Tc-99m-DTPA, entrapped in multilamellar lipid vesicles
43. Investigations of a new, highly negative liposomes with improved biodistribution for imaging
44. Assessment of the potential uses of liposomes for lymphoscintigraphy and lymphatic drug delivery Failure of 99m-technetium marker to represent intact liposomes in lymph nodes
45. Effect of liposome surface charge on the stability of technetium (99mTc) radiolabeled liposomes
46. Labeling preformed liposomes with 67Ga or 99mTc by chelation
47. Liposomes prepared from synthetic amphiphiles I. Their technetium labeling and stability
48. Attachment of 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanoIamine-DTTA
49. Modes of interaction of (In3+)-8-hydroxyquinoline with membrane bilayer
50. Preparation of lipid vesicles containing high levels of entrapped radioactive cations
51. An efficient method for loading indium-111 into liposomes using acetylacetone
52. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo
53. Technetium-99m HM-PAO stereoisomers:differences in interaction with glutathione
54. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione
55. Nuclear magnetic relaxation dispersion and 31P NMR studies of the effect of co valent modification of membrane surfaces with poly(ethylene glycol)
56. Preservation of liposomes by freeze-drying
57. Paramagnetic ions trapped in phospholipid vesicles as contrast agents in NMR imaging I. Mn-citrate in phosphatidylcholine and phosphatidylserine vesicles
58. Liposomes containing paramagnetic molecules as MRI contrast agents
59. Liposome delivery of NMR contrast agents for improved tissue imaging
60. Liposomal Gd-DTPA: preparation and characterization of relaxivity
61. Liposomal Paramagnetic Magnetic Resonance Contrast Agents
62. Modulation of water permeation rates by liposomes containing paramagnetic materials
63. The effect of lipid composition on the relaxivity of Gd-DTPA entrapped in lipid vesicles of defined size
64. Permeability of liposomal membranes to water: results from the magnetic field dependence of 1/T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions
65. A phospholipid spinlabel used as a liposome associated MRI contrast agent
66. Gadolinium-labeled liposomes containing paramagnetic amphipathic agents
67. Small unilamellar liposomes as magnetic resonance contrast agents loaded with paramagnetic Mn-, Gd- and Fe-DTPA-stearate complexes
68. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives:Targeted MRI contrast agents for the liver
69. From the relaxivity of Gd(DTPA)2- to everything else
70. The design of liposomal paramagnetic MR agents: Effect of vesicle size upon the relaxivity of surface-incorporated lipophilic chelates
71. Polymorphic phase behavior of unsaturated lysophosphatidylethanolamines: A 3 IP NMR and x-ray diffraction study
72. 31P nuclear magnetic resonance and the head group structure of phospholipids in membranes